USFDA nod to Vidaza negative for Dr Reddy’s

Dr Reddy's stock has gained negative surprise after two drug companies Mylan and Actavis have got a USFDA nod for making gVidaza.
Share this Video

READ MORE:

Mylan |Actavis |USFDA nod |Vidaza |gvidaza |dr reddy stock down
appinstlBnr
Business News › ET Now › Experts › USFDA nod to Vidaza negative for Dr Reddy’s
Open in App

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Download ET APP


Follow us on


Powered by

become a member

Terms of Use & Grievance Redressal Policy
DNPA Code of Ethics|Privacy Policy|Archive|Delete Data|Feedback|

Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service

Do Not Sell My Personal Information
Success
This article has been saved